Here are three takeaways:
1. Mazor and its partner, Medtronic, will team up to commercialize, co-promote and market the platform.
2. Medtronic made a $40 million third trance investment in the robotics company this year.
3. During the second quarter, Mazor received 16 Mazor X purchase orders in the U.S. The company anticipates the CE mark will increase purchases in Europe.
More articles on devices:
16 new spine, orthopedic device launches & releases — Sept. 27, 2017
OrthAlign raises $10M in financing for research & development expansion: 5 insights
Onkos Surgical launches Precision Oncology Platform: 5 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
